One claim I find especially annoying is when people say conservatives don’t have ideas for health reform. That absolutely, positively is not true! It’s lazy to cite one thumbs-down vote by a particular senator in 2017 as the final say on the matter. We and our colleagues in the Health Policy Consensus Group offer a plethora of ideas and proposals—which are … [Read more...] about The right way to save Medicare
Published in Forbes
Grace-Marie frequently contributes articles to Forbes.com as an expert in Healthcare Policy.
Don’t Destroy Future Drug Development
Forbes | December 8, 2021 | With support faltering for the massive big-government blowout Congress is trying to jam through by Christmas, Senate leaders would be wise to take a more efficient, bi-partisan approach to solving problems and modernizing hide-bound government programs. How about a new approach…Build Back Bipartisanship. Take, for example, the drug pricing provisions in the … [Read more...] about Don’t Destroy Future Drug Development
Folly And Waste — Brian Blase In Forbes
CBO Confirms the Folly and Waste of Expanded Obamacare Subsidies by Brian Blase | Forbes, October 20, 2021 | A new report from the Congressional Budget Office (CBO) shows that expanding Affordable Care Act (ACA) subsidies is poor public policy.CBO projects that expanding the ACA, which includes increased premium subsidies for exchange insurance as well as a new federal Medicaid … [Read more...] about Folly And Waste — Brian Blase In Forbes
Biden Seeks To Build On Many Of Trump’s Health Care Policies
On July 9, 2021, President Biden signed an executive order designed to promote competition throughout the American economy. Most of the Biden administration’s health-related proposals in this order either build on policies implemented by the Trump administration or are consistent with Trump administration direction. Republicans should work to support many of the reforms, particularly … [Read more...] about Biden Seeks To Build On Many Of Trump’s Health Care Policies
Bundled Payment For Dialysis Patients Can Block Access To Innovative Treatments
by Grace-Marie Turner | Forbes | June 1, 2020 | Bundled payments are a good idea, until they aren’t—for patients. The idea of paying a combined price rather than piecemeal for a routine medical treatment or procedure has gained traction as a way of driving efficiency. You wouldn’t want to buy a car by ordering a carburetor, ignition, fuel tank, braking system, etc. But when the government … [Read more...] about Bundled Payment For Dialysis Patients Can Block Access To Innovative Treatments
The “Family Glitch” Administrative Fix Under Consideration By The Biden Administration Remains Both Illegal And Harmful
by Brian Blase | Forbes | The Galen Institute released a short analysis I conducted explaining why an administrative fix to the Affordable Care Act’s (ACA’s) so-called family glitch would be both illegal and harmful. Dania Palanker, with the Georgetown University Health Policy Institute, criticized the analysis I conducted, saying it was not based on the administrative fix the Biden … [Read more...] about The “Family Glitch” Administrative Fix Under Consideration By The Biden Administration Remains Both Illegal And Harmful
How the ACA Failed–Brian Blase for Forbes
In a new Forbes piece, Galen Institute senior fellow and former special assistant to the president at the National Economic Council Brian Blase, discusses the ACA’s failures and how Trump administration reforms have helped. According to Blase: The Affordable Care Act (ACA), or Obamacare, was principally intended to improve health insurance markets for individuals and small … [Read more...] about How the ACA Failed–Brian Blase for Forbes
Say No To Importing Foreign Price Controls On Drugs
Grace-Marie Turner | Forbes | President Trump has doubled down on the Executive Order he put on hold in July that threatened to import price controls from countries with government-run health systems and use them as a basis for what Medicare pays for certain drugs. The new order proposes a “Most Favored Nation” (MFN) pricing scheme not only on more expensive specialty drugs paid under … [Read more...] about Say No To Importing Foreign Price Controls On Drugs